PRECLINICAL FEATURE ARTICLES
PRECLINICAL WHITE PAPERS & ARTICLES
-
![GettyImages-1293373244 clinical team]( "Altasciences’ Facilities Moving In Unison")
With nine facilities across North America, explore our integrated, comprehensive solution for all your early-phase drug development needs and unique expertise.
-
![MRI-brain-head]( "Navigating The FDA’s Draft Guidance On Psychedelic Drug Development")
Uncover new guidance for the development of innovative therapies in the realm of mental health and addiction treatment.
-
![GettyImages-1359273311 office]( "Psychedelics As Therapeutics – What Developers Need To Know")
Drug developers and others intrigued by the dynamic and promising field of psychedelics as therapeutics can gain valuable guidance from a recap of the 3rd annual Psychedelic Therapeutic and Drug Development Conference.
-
![GettyImages-1443973272 research]( "The Criticality Of CMO Selection For Small Biopharma Companies")
Delve into the criteria that small or early-stage biopharma companies should consider during their CMO selection process, along with key considerations to keep in mind.
-
![GettyImages-1346675513 lab materials]( "Raw Materials Control For Biotechs (Part 1)")
Navigate challenges posed by raw material usage and learn how to lay a robust current Good Manufacturing Practices groundwork for a control program.
PRECLINICAL APPLICATIONS & STUDIES
-
A Versatile Application For Rapid Mass Confirmation And Purity Assessment Of Biotherapeutics7/18/2022
We explore a streamlined integrated workflow for data acquisition, processing and reporting of deconvoluted mass data for biotherapeutics, deployable in regulated and non-regulated environments.
-
Transferring N-Glycan HILIC Separations Between UPLC And HPLC7/18/2022
We demonstrate that comparable chromatographic profiles and relative quantitation can be achieved with the larger particle size column at HPLC-compatible pressures, albeit with an increase in sample load, mobile phase use, and most importantly, analysis time.
-
Improving Released N-glycan Analysis In Biotherapeutic Development Using Premier Solution With HPS Technology7/12/2022
Explore how we improved releasing N-glycan analysis in biotherapeutic development, which can help develop robust and unbiased glycan assays for biotherapeutic development, manufacture, and release.
-
Method Migration Of Size-Exclusion And Ion- Exchange Methods For Monoclonal Antibody Analysis7/12/2022
Discover how combining this system with modern UHPLC columns could make data more accurately interpreted through greater efficiency, selectivity, and enhanced resolution.
-
Rapid Size Variant Analysis of Monoclonal Antibodies Using SEC Columns7/9/2022
This study examines technological advancements in both the column hardware and packed particle chemistry of solution that provides extended column lifetimes when using physiological pH mobile phases.
PRECLINICAL PRODUCTS & SERVICES
Novotech initiated the first national, privately owned, commercial Institutional Biosafety Committee (IBC) in Australia, successfully accredited by the Australian Office of the Gene Technology Regulator (OGTR).
PRECLINICAL SUPPLIERS
-
![SAE / ADR / MDR Management]( "PRA Health Sciences")
PRA is a global Clinical Research Organization providing services through all phases of clinical development. PRA has supported over 3,100 clinical trials in more than 80 countries on 6 continents through our global offices. PRA's therapeutic expertise, global reach, and project experience with local knowledge enable our project teams to deliver consistent and on time performance for our clients.
-
![MPI Research]( "MPI Research")
MPI Research, with global headquarters in Mattawan, Michigan, provides discovery, safety evaluation, bioanalytical, and analytical services to the biopharmaceutical, medical device, animal health, and chemical industries.
PRECLINICAL & CLINICAL TRIAL NEWS
- Harlan Laboratories Continues Global Growth With Major Expansion Of North American Facilities
- La Jolla Pharmaceutical Company Announces Completion Of Phase 1 Portion Of GCS-100 Clinical Trial In Chronic Kidney Disease
- DSM And DecImmune Therapeutics Sign Agreement To Develop N2 Pathway Blocking Antibody
- Catabasis Initiates Phase 1 Trial Of CAT-2003 For Treatment Of Severe Hypertriglyceridemia
- Spanish Biotech PharmaMar Selects Medidata Clinical Cloud To Accelerate Trials For Marine-Based Oncology Drugs
- Cubist Announces Exclusive Option To Acquire Adynxx
- The Michael J. Fox Foundation Launches New Funding Opportunities For Parkinson's Research
- Ability Pharmaceuticals Awarded A 1.2 Million Euros Grant To Develop Its Lipid Analog ABTL0812 For Lung And Pancreatic Cancer
- Reaxys® Medicinal Chemistry Provided As Part Of Elsevier’s Suite Of Life Science
- DiaMedica Successfully Completes DM-199 cGMP Manufacturing And Pre-Clinical Toxicology Safety Studies
- Savant HWP Announces NIDA Funding For Pre-Clinical Development Of 18-MC As Potential Treatment For Addiction, Obesity
- Bio-Matrix' Regen BioPharma Initiates Pre-Clinical Study In Support Of HemaXellerate™ Cell Therapy
- ClinicalRM Awarded Contract For Regulatory, Clinical And Technical Services To Support The U.S. Army Medical Materiel Development Activity (USAMMDA)
- Accelovance Strengthens Executive Team With Chief Medical Officer